6 Αποτελέσματα
Throughout this application various publications are referenced in parenthesis. The disclosures of these publications in their entireties are hereby incorporated by reference into this application in order to more fully describe the state of the art to which this invention pertains.
BACKGROUND OF
Throughout this application various publications are referenced in parenthesis. The disclosures of these publications in their entireties are hereby incorporated by reference into this application in order to more fully describe the state of the art to which this invention pertains.
BACKGROUND OF
This application is a U.S. national stage of PCT/EP2010/002046 filed on Mar. 31, 2010 which claims priority to and the benefit of Italian Application No. MI2009A000548 filed on Apr. 6, 2009, the contents of which are incorporated herein by reference.
The present invention relates to a process for
This application is a 371 of PCT/FR02/02519 filed Jul. 16, 2002.
The present Patent Application relates to the use of extracts of Ginkgo biloba for preparing a medicament intended to treat sarcopenia.
Sarcopenia is a muscular affection which effects most older people and manifests as a reduction in
The present Patent Application relates to the use of extracts of Ginkgo biloba for preparing a medicament intended to treat sarcopenia.
Sarcopenia is a muscular affection which effects most older people and manifests as a reduction in their muscle mass with age (cf. for example Chumlea et al.,
FIELD OF THE INVENTION
This invention relates to a novel composition of Ginkgo Biloba extract (GBE) and edible polyol or combination of edible polyols which increase the bioavailability of GBE, providing increased serum levels of GBE and decreased urine levels of GBE for a given dose over GBE